CEL-SCI Corp. Insider Acquires $6,636 in Stock (CVM)
CEL-SCI Corp. (NYSE:CVM) Insider Geert Kersten purchased 8,400 shares of CEL-SCI Corp. stock on the open market in a transaction dated Wednesday, October 9th. The shares were purchased at an average cost of $0.79 per share, for a total transaction of $6,636.00. Following the completion of the acquisition, the insider now directly owns 425,227 shares in the company, valued at approximately $335,929. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
CEL-SCI Corp. (NYSE:CVM) traded up 0.01% on Friday, hitting $0.8404. 677,814 shares of the company’s stock traded hands. CEL-SCI Corp. has a one year low of $0.77 and a one year high of $3.90. The stock’s 50-day moving average is $1.76 and its 200-day moving average is $2.23. The company’s market cap is $26.0 million.
CEL-SCI Corp. (NYSE:CVM) last issued its quarterly earnings data on Monday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter. Analysts expect that CEL-SCI Corp. will post $-0.40 EPS for the current fiscal year.
CEL-SCI Corporation (NYSE:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.